AMNEAL PHARMACEUTICALS INC's ticker is and the CUSIP is 03168L905. A total of 3 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,450 | +798.1% | 47,500 | +559.7% | 0.00% | – |
| Q2 2023 | $22,320 | +919.6% | 7,200 | +554.5% | 0.00% | – |
| Q4 2022 | $2,189 | +9.4% | 1,100 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -96.7% | 1,100 | -94.3% | 0.00% | – |
| Q2 2022 | $61,000 | -29.9% | 19,300 | -7.7% | 0.00% | – |
| Q1 2022 | $87,000 | -51.9% | 20,900 | -44.7% | 0.00% | – |
| Q4 2021 | $181,000 | +147.9% | 37,800 | +177.9% | 0.00% | – |
| Q3 2021 | $73,000 | -62.6% | 13,600 | -64.2% | 0.00% | – |
| Q2 2021 | $195,000 | -24.1% | 38,000 | -0.5% | 0.00% | – |
| Q1 2021 | $257,000 | -28.0% | 38,200 | -51.1% | 0.00% | -100.0% |
| Q4 2020 | $357,000 | +466.7% | 78,100 | +491.7% | 0.00% | – |
| Q2 2020 | $63,000 | +270.6% | 13,200 | +169.4% | 0.00% | – |
| Q1 2020 | $17,000 | -69.6% | 4,900 | -57.8% | 0.00% | – |
| Q4 2019 | $56,000 | +700.0% | 11,600 | +364.0% | 0.00% | – |
| Q3 2019 | $7,000 | -91.9% | 2,500 | -79.2% | 0.00% | -100.0% |
| Q2 2019 | $86,000 | -70.2% | 12,000 | -41.2% | 0.00% | -66.7% |
| Q1 2019 | $289,000 | -32.5% | 20,400 | +5.7% | 0.00% | 0.0% |
| Q3 2018 | $428,000 | +38.1% | 19,300 | +2.1% | 0.00% | 0.0% |
| Q2 2018 | $310,000 | – | 18,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 19,300 | $61,000 | 0.00% |
| SIMPLEX TRADING, LLC | 9,700 | $30,000 | 0.00% |